EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Spatial transcriptomics mapping of immune cell and TGFβ signalling pathway heterogeneity in testicular germ cell tumours

Sarah C Moody, Daniela Fietz, Benedict Nathaniel, Mark Frydenberg, Ben Tran, Hans-Christian Schuppe, Kate L Loveland

Andrology · 2026

DOI: 10.1111/andr.70100 ↗

At a glance

Journal article in Andrology, 2026. Written by Sarah C Moody and 6 co-authors. Institution: Centre for Reproductive Health, Hudson Institute of Medical Research, Clayton, Victoria, Australia. Major MEDLINE topics: Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal, Transforming Growth Factor beta, Transcriptome. Cited 4 times so far (Crossref); 74 references. The full text is freely available (open access, CC BY 4.0). Funded by: European Cooperation in Science and Technology, Deutsche Forschungsgemeinschaft, National Health and Medical Research Council.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Testicular germ cell tumours (TGCTs) are amongst the most common malignancies in young men, and their incidence is increasing worldwide. Tissue heterogeneity hampers efforts to understand how TGCT precursors (termed germ cell neoplasia in situ; GCNIS) emerge and progress, restricting elucidation of new strategies for diagnosis and management.

Objectives

This study reports the use of spatial transcriptomic analysis in TGCT tissue sections. Materials and methods Over 90 regions of interest (ROIs) were identified in sections from four TGCT patients’ samples, three with non‐seminoma, one seminoma. Transcripts in each ROI were sequenced and examined using the NanoString GeoMx spatial whole transcriptomics workflow, the values normalised and analysed using Degust RNA‐Seq and Ingenuity Pathway Analysis software.

Results

The distribution and expression of functional markers in specific cell types was used to map individual tumours, GCNIS, and tumour‐adjacent regions. Significant heterogeneity in TGCTs and surrounding areas is documented between patients and across different regions in the same tumour. Immune cell‐related transcripts encoding macrophage, T cell, B cell, natural killer cell, dendritic cells and neutrophil subsets were identified as contributing substantially to tumour heterogeneity. Assessment of ROIs containing GCNIS and areas immediately adjacent from two individual non‐seminoma tumour samples identified the TGFβ family as contributing to upstream regulation of transcripts in both patients; known activin A target genes were differentially expressed between the GCNIS and microenvironment ROIs. In addition, two discrete tumour areas within the seminoma sample displayed distinct transcript profiles, one featuring higher levels of immune cell‐related transcripts, and the other TGFβ superfamily transcripts.

Conclusion

These findings highlight aspects of the complex challenge faced while seeking therapeutic targets to enable tumour spread restriction. However, these outcomes reinforce knowledge that TGFβ family members can influence seminoma fate and provide new evidence of their potential contribution to the transition of GCNIS cells into tumours.

Subjects

MeSH terms (MEDLINE)

Testicular NeoplasmsNeoplasms, Germ Cell and EmbryonalTransforming Growth Factor betaTranscriptomeSeminomaHumansMaleSignal TransductionGene Expression ProfilingTumor Microenvironment

Author keywords

NanoStringTGFβ signalling pathwaycancer immunobiologyinterferon gammatestis cancertumour heterogeneity

Substances

Transforming Growth Factor beta

Authors and institutions

  • Centre for Reproductive Health, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Department of Molecular and Translational Sciences, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
  • Institute of Veterinary Anatomy, Histology and Embryology, Justus-Liebig University Giessen, Giessen, Germany.
  • Department of Surgery, FMNHS, Monash University, Melbourne, Victoria, Australia.
  • Department of Urology, Cabrini Institute, Cabrini Health, Melbourne, Victoria, Australia.
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Funding

  • European Cooperation in Science and Technology
  • Deutsche Forschungsgemeinschaft
  • National Health and Medical Research Council

Cite

APA

Moody, S. C., Fietz, D., Nathaniel, B., Frydenberg, M., Tran, B., Schuppe, H. C., & Loveland, K. L. (2026). Spatial transcriptomics mapping of immune cell and TGFβ signalling pathway heterogeneity in testicular germ cell tumours. Andrology. https://doi.org/10.1111/andr.70100

Vancouver

Moody SC, Fietz D, Nathaniel B, Frydenberg M, Tran B, Schuppe HC, et al. Spatial transcriptomics mapping of immune cell and TGFβ signalling pathway heterogeneity in testicular germ cell tumours. Andrology. 2026. doi:10.1111/andr.70100

BibTeX
@article{Moody2026,
  author = {Moody, Sarah C and Fietz, Daniela and Nathaniel, Benedict and Frydenberg, Mark and Tran, Ben and Schuppe, Hans-Christian and Loveland, Kate L},
  title = {Spatial transcriptomics mapping of immune cell and TGFβ signalling pathway heterogeneity in testicular germ cell tumours},
  journal = {Andrology},
  year = {2026},
  doi = {10.1111/andr.70100}
}
Start for free →